These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27236109)

  • 21. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of CHA
    Hu WS; Lin CL
    Intern Emerg Med; 2019 Apr; 14(3):395-402. PubMed ID: 30306322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.
    Willens HJ; Gómez-Marín O; Nelson K; DeNicco A; Moscucci M
    J Am Soc Echocardiogr; 2013 Feb; 26(2):175-84. PubMed ID: 23253435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of the CHA2DS2-VASC Score to Predict Adverse Outcomes in Patients Having Percutaneous Coronary Intervention.
    Orvin K; Bental T; Assali A; Lev EI; Vaknin-Assa H; Kornowski R
    Am J Cardiol; 2016 May; 117(9):1433-8. PubMed ID: 27001448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
    Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
    Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of red cell distribution width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation.
    Kurt M; Tanboga IH; Buyukkaya E; Karakas MF; Akçay AB; Sen N
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):687-92. PubMed ID: 23430929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
    Glotzer TV; Hellkamp AS; Lee KL; Lamas GA
    Can J Cardiol; 2015 Aug; 31(8):1004-11. PubMed ID: 26076964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHA
    Bozbay M; Uyarel H; Cicek G; Oz A; Keskin M; Murat A; Yildirim E; Karaca G; Ergelen M; Eren M
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):132-138. PubMed ID: 27170782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis.
    Conrotto F; D'Ascenzo F; D'Onofrio A; Agrifoglio M; Chieffo A; Cioni M; Regesta T; Tarantini G; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stolcova M; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Gerosa G; Gaita F; Rinaldi M; Salizzoni S
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):867-873. PubMed ID: 27354254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade.
    Haghjoo M; Nikoo MH; Fazelifar AF; Alizadeh A; Emkanjoo Z; Sadr-Ameli MA
    Europace; 2007 May; 9(5):328-32. PubMed ID: 17369270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting postoperative atrial fibrillation using CHA2DS2-VASc scores.
    Kashani RG; Sareh S; Genovese B; Hershey C; Rezentes C; Shemin R; Buch E; Benharash P
    J Surg Res; 2015 Oct; 198(2):267-72. PubMed ID: 26004496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of newly defined CHA2DS2-VASc-HSF score for severity of coronary artery disease in ST segment elevation myocardial infarction.
    Uysal OK; Turkoglu C; Duran M; Kaya MG; Sahin DY; Gur M; Cayli M
    Kardiol Pol; 2016; 74(9):954-60. PubMed ID: 27112941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting the Outcomes of Acute Ischemic Stroke with Rheumatic Heart Disease: The Values of CHADS2, CHA2DS2-VASc, and HAS-BLED Scores.
    Liu J; Wang D; Tan G; Yuan R; Xu M; Xiong Y; Liu M
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):722-6. PubMed ID: 26774873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S; Lane DA; Buller H; Lip GY
    Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
    Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
    Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.
    Parikh MG; Aziz Z; Krishnan K; Madias C; Trohman RG
    Am J Cardiol; 2012 Feb; 109(4):550-5. PubMed ID: 22133753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.